Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MASH”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07332611
What this trial is testing

Long Term Prediction of MASH-related HCC Risk by Proteomics

Who this might be right for
MASH-related HCC
University Hospital, Bordeaux 30
Not applicableStudy completedNCT06741111
What this trial is testing

A Real-world Assessment in Implementation of the MASH Patient Care Pathway in Chinese Population Using the Meinian Health Check-up Database

Who this might be right for
Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) & Steatohepatitis (MASH)
Novo Nordisk A/S 1,233,970
Large-scale testing (Phase 3)Looking for participantsNCT07704892
What this trial is testing

Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)

Who this might be right for
Metabolic Dysfunction-associated Steatohepatitis
GlaxoSmithKline 380
Not applicableLooking for participantsNCT05651724
What this trial is testing

Global Research Initiative for Patients Screening on MASH

Who this might be right for
MASHMASLDMASH With Fibrosis+6 more
Julius Clinical 10,000
Testing effectiveness (Phase 2)Looking for participantsNCT07527910
What this trial is testing

A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Regeneron Pharmaceuticals 204
Large-scale testing (Phase 3)Looking for participantsNCT06419374
What this trial is testing

Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

Who this might be right for
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
89bio, Inc. 762
Testing effectiveness (Phase 2)Looking for participantsNCT07512427
What this trial is testing

Phase 1/2 Study of OPK-88006 in Healthy and Presumed MASH Participants

Who this might be right for
MASH
OPKO Health, Inc. 30
Testing effectiveness (Phase 2)Study completedNCT06410924
What this trial is testing

Evaluate DD01 in Overweight/Obese Subjects With MASLD/MASH

Who this might be right for
NAFLDNASH
Neuraly, Inc. 67
Testing effectiveness (Phase 2)Looking for participantsNCT06937749
What this trial is testing

IBI362 in Participants With Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Who this might be right for
Metabolic Dysfunction-associated Steatohepatitis (MASH)
Innovent Biologics (Suzhou) Co. Ltd. 165
Large-scale testing (Phase 3)Looking for participantsNCT06632444
What this trial is testing

LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

Who this might be right for
Metabolic Dysfunction Associated Steatohepatitis (MASH)Liver Fibrosis
Boehringer Ingelheim 1,800
Not applicableLooking for participantsNCT06813508
What this trial is testing

Prognostic Factors for HCC and Liver Transplantation in Patients With MASLD/MASH

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseHepatocellular CarcinomaMetabolic Dysfunction-Associated Steatohepatitis+1 more
IRCCS Azienda Ospedaliero-Universitaria di Bologna 1,000
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07025980
What this trial is testing

Effect of Sinbiotic With Multispecies Probiotics on Liver Parameters Liver Enzymes, Ultrasound, Elastography and Adipokines in Same Cases) in Patients With Metabolic Associated Steatotic Liver Disease.

Who this might be right for
MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)Diabetes MellitusHypertension+1 more
Eva Cubric
Not applicableEnded earlyNCT02864940
What this trial is testing

Memory Training in Aneurysmal Subarachnoid Hemorrhage Patients

Who this might be right for
Ruptured AneurysmMemory DeficitsSubarachnoid Hemorrhage
Rush University Medical Center 38
Not applicableNot Yet RecruitingNCT07530419
What this trial is testing

Samsung S-Viscosity vs Canon Dispersion Slope in Steatotic Liver Disease (SAVID-SLD)

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseFatty LiverLiver Fibrosis
Seoul National University Hospital 95
Early research (Phase 1)Not Yet RecruitingNCT07724431
What this trial is testing

A Phase 1, Double-blind, Randomized Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Single Dose and Multiple Doses of CG-0416 in Healthy Participants.

Who this might be right for
Overweight and Obesity
HongKong Curegene Innovation Co., Limited 64
Testing effectiveness (Phase 2)Looking for participantsNCT07660848
What this trial is testing

HRS-4729 Injection and HRS9531 Injection in Participants With Metabolic Dysfunction-Associated Steatohepatitis

Who this might be right for
Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Fujian Shengdi Pharmaceutical Co., Ltd. 160
Post-approval studies (Phase 4)Not Yet RecruitingNCT07680478
What this trial is testing

Nutrition Intervention Combined With Resmetirom for MASH

Who this might be right for
Metabolic Dysfunction-Associated Steatohepatitis (MASH)
City University of New York 120
Not applicableEnrolling By InvitationNCT06986447
What this trial is testing

Assessment of Non-Invasive Testing in Major Liver-Related Outcomes

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseMASLDMASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease+2 more
HRI-MAIL-NIT 1,689
Not applicableLooking for participantsNCT07083557
What this trial is testing

Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)

Who this might be right for
Obesity and Obesity-related Medical ConditionsDiabetesAtherosclerotic Disease+11 more
Bettina Mittendorfer 100
Post-approval studies (Phase 4)Looking for participantsNCT07058155
What this trial is testing

Optimizing Portal Hypertension With TIPS and Interval Metabolic Surgery for Advanced Liver Disease

Who this might be right for
Liver CirrhosesPortal Hypertension Related to CirrhosisSevere Obesity+1 more
The Cleveland Clinic 70
Next Page
114